Table 1 Descriptive analysis of clinical and biochemical characteristics for the patients with or without ophthalmoplegia in the study cohort Sample according to cranial nerve palsy
Variables | Total sample (n = 64,351) | Ophthalmoplegia | Cranial nerve palsy | |||||
|---|---|---|---|---|---|---|---|---|
Non Affected (n = 64,142) | Affected (n = 209) | P value | III (n = 76) | IV (n = 6) | VI (n = 111) | Multiple (n = 16) | ||
Mean Age | 55.92 ± 14.50 | 55.89 ± 14.51 | 63.25 ± 9.59 | <0.0001 | 65.17 ± 8.04 | 64.17 ± 9.11 | 61.47 ± 9.92 | 66.13 ± 12.27 |
Mean BMI | 30.47 ± 6.48 | 30.48 ± 6.48 | 29.24 ± 5.30 | 0.015 | 28.93 ± 5.43 | 27.20 ± 2.08 | 29.49 ± 5.28 | 29.75 ± 6.09 |
Mean DM duration | 13.17 ± 8.05 | 13.15 ± 8.05 | 17.90 ± 7.59 | <0.0001 | 17.15 ± 6.86 | 14.67 ± 4.50 | 18.20 ± 8.21 | 20.50 ± 6.93 |
Mean HbA1c | 8.88 ± 2.39 | 8.88 ± 2.39 | 8.75 ± 2.19 | 0.791 | 9.14 ± 2.32 | 9.50 ± 0.00 | 8.45 ± 2.28 | 8.10 ± 2.12 |
Mean FBS (mmol/l) | 10.02 ± 4.40 | 10.02 ± 4.40 | 10.53 ± 4.42 | 0.402 | 10.98 ± 4.92 | 8.60 ± 3.21 | 10.61 ± 4.35 | 8.70 ± 0.71 |
Mean RBS (mmol/l) | 12.82 ± 5.63 | 12.81 ± 5.63 | 14.87 ± 5.58 | 0.005 | 14.52 ± 5.56 | 15.55 ± 0.21 | 14.94 ± 5.77 | 15.59 ± 6.56 |